A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea
Clinical trial NCT03276936 · COMPLETED
Trial details
- NCT number
- NCT03276936
- Sponsor
- Vyne Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-05
- Primary completion
- 2019-01-03
- Enrollment
- 504
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.